Abstract PS1-08-13: A retrospective study to assess real world rates of dose modification, therapy discontinuation and treatment outcomes in patients receiving the oral CDK4/6 inhibitors Ribociclib and Palbociclib
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: C. Steele, J. Shaw, D. O'Connor, K. Dunne, D. O'Mahony, C. Murphy
Institutions: Bon Secours Hospital Cork, University College Cork
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129313905
Cites:
Cited by:
Related to: